GBM Stories: Kyle Coddington
Kyle Coddington’s glioblastoma story
Australian professor Richard Scolyer documents his glioblastoma journey
Prof. Richard Scolyer is an Australian pathologist who’s bravely sharing his GBM journey
Cancer Moonshot
The Cancer Moonshot is focused on increased investment, data collaboration, quality of life for people with cancer, including brain tumors like glioblastoma, and more.
OurBrainBank announces new Executive Director
OurBrainBank welcomes Kelli Duprey as new Executive Director.
GBM Stories: Patrick Koske-McBride
Patrick writes with intelligence and dark humor about what’s like living with GBM.
Website highlight: Newly Diagnosed with Glioblastoma?
You can feel alone and isolated, but help is at hand. Find out about the GBM Standard of Care, important questions to ask your doctor, tissue collection, and requesting a second opinion.
Adam Hayden: Glioblastoma community leader (1982-2025)
Long-term GBM survivor Adam Hayden’s hot take on living with a brain tumor.
Brain Breakthrough: RI researchers working to make progress against glioblastoma (TV news story)
WPRI reporter Ted Nesi covers new treatments for GBM and talks about his own personal experience losing a loved one to this terrible disease.
Op-ed by Board Member Sundas Hashmi
There’s a ticking time bomb in my head. I’m learning to live with it.
Like most people in treatment for brain tumors in the United States, I’ve had to adapt to a mind that feels very different from the one I once knew.
Two substantial health reports are released today in the UK.
Two substantial health reports are out today in the UK.
Demand More! Help us make the Glioblastoma Bill of Rights a reality
Our survey showed serious disparities in GBM care across the USA. Let’s tell the country and make change!
OBB working with a group of brain tumour charities and a non-profit to ensure that patients have timely access to innovative treatments
We have been collaborating in the UK with a group of brain tumour charities and a non-profit organisation to ensure that patients have timely access to innovative treatments.
SUBSCRIBE TO OUR NEWSLETTER
GET INVOLVED
